Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke

Summary

To assess the efficacy and to evaluate safety of HT047 in patients with acute ischemic stroke

Timeline

Start

2016-08-04

Primary completion

2018-08-03

Completion

2018-08-03

Publications

• Heo SH, Song J, Kim BJ, Kim H, Chang DI; HT047 investigators. Rationale and design to assess the efficacy and safety of HT047 in patients with acute ischemic stroke: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase II trial. Medicine (Baltimore). 2019 Oct;98(43):e17655. doi: 10.1097/MD.0000000000017655.

Drugs

Indications